Year: 1987
Type: article
Abstract: Triazolam premedicationWe have read with interest the paper on triazolam premedication by Dr Thomas et a / .(Anaesthesia 1986; 41: 692).In particular, the conclusion that triazolam 0.25 mg produced effective preoperative anxiolysis is surprising in vicw of the results presented.Thcrc was no difference between the groups.but patients who received triazolam were judged to be less anxious than baseline while in the anaesthetic room.This appears to be the only evidence for the improvement in anxiety upon which the conclusion is based and, therefore, some further explanation is required.We are told that one of the authors assessed thc patients pre-and postoperatively, but it could be construed that thc anaesthetist was the assessor in the anaesthetic room.A different assessor used at this time would serve to lessen the precision of the test and cast doubt upon the validity of the observation.The use of the linear analogue score (LAS) for anxiety has been cstablished' but, as far as we know, this has been confined to use by the patient only in quantifying a subjective variable.Has the use of the LAS by an observer to measure subjective effects in the patient bccn cvaluated?It is regrettable that no account was taken of the patient's own assessment of anxiety.Forrest er questioned the reliability of conclusions based solely on observer assessments of anxiolysis, in view of the disagreement between observers and patients in this measurement.In the study of Thomas et al., no changes in perceived anxiety were noted by patients who received triazolam, and no reduction in anxiety was denionstrated using the multiple affect adjective check list (MAACL).This result accords with the patient assessments in the study by Pinnock et aL4 and, therefore, conflicts with the overall conclusion in respect of the usefulness of triazolam.Unfortunately, no data are given in Table 3 for the patient's assessment in the anaesthetic room, of sleepiness, but the observers rated all patients more sleepy than at baseline, with a mean increment in those who received triazolam of 350% as compared to 188% and 170%' increments in the lorazepam and placebo groups, respectively.This would seem to indicate a trend in favour of a sedative and hypnotic effect of triazolam at this time.Regarding recovery at 6 hours from undesirable side effects, no data are given for the linear analogue dizziness scores assessed by the patients 6 hours postoperatively, but we are told that all patients were less clear-headed (that is, more dizry) than at baseline.If the influence of the increase in dizziness at 2 hours (8SO% for triazolam and 300% for the other groups) is apparent at 6 hours, then it would seem that triazolam could not be recommended for use in patients who are to be discharged at that time.The authors state that: 'The need for pharmacological premedication is demonstrated by the
Source: Anaesthesia
Authors: T. Tipping, C. E. Blogg, D. Thomas
Institutions: John Radcliffe Hospital, University of Oxford
Language: English
Open Access status: bronze
OpenAlex ID: W4233971778
